跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,781 条关于
“mismatch repair–deficient”
全部
11,781
临床试验
10,090
药物
85
机构
32
资讯
1,574
去年
Dostarlimab Shows Promise in Eliminating Need for Surgery Across Multiple dMMR Cancer Types
2个月前
Immunotherapy Alone Achieves Complete Response in Mismatch Repair-Deficient Gastroesophageal Junction Cancer, Sparing Patient from Chemotherapy and Surgery
去年
INSPIRE Trial: Nivolumab and Ipilimumab Show Promise in Mismatch Repair-Deficient Metastatic Prostate Cancer
去年
Molecular Testing Drives Personalized Treatment Approaches in Endometrial Cancer
去年
GSK's Cancer Portfolio Gains Momentum with Regulatory Successes for Dostarlimab and GSK'227
去年
Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer
2年前
FDA Approves New Endometrial Cancer Therapies, Expanding Treatment Options
去年
Agilent's MMR IHC Panel PharmDx Receives FDA Approval as Companion Diagnostic for Colorectal Cancer Immunotherapy
去年
Spatial Analysis Reveals Tumor-Stroma Boundary Organization Impacts Immunotherapy Response in Colorectal Cancer
去年
Dostarlimab Achieves 100% Remission in Small-Scale Colorectal Cancer Trial
第 1 页,共 158 页
上一页
下一页